Mounjaro (tirzepatide) is a weekly injection that activates two gut-hormone receptors — GLP-1 and GIP — at the same time, which helps reduce appetite and support weight loss, and which is also relevant to people living with type 2 diabetes. It is a prescription-only medicine, available only after a clinical consultation with a GPhC-registered prescriber who checks it is suitable for you.
Below is a plain-English guide to how Mounjaro works on both weight and blood sugar, who it may suit, and what to be aware of. It is educational information, not a recommendation — only a prescriber can decide whether treatment is appropriate for you.
How does Mounjaro work on both weight and blood sugar?
Mounjaro (tirzepatide) activates two gut-hormone receptors at once — GLP-1 and GIP. These are hormones your body releases naturally after eating, and they influence appetite, how full you feel, and how your body handles blood sugar.
By mimicking these hormones, Mounjaro can help you feel fuller sooner and for longer, which supports eating less and losing weight. The same gut-hormone pathways are also involved in blood-sugar regulation, which is why tirzepatide is studied in the context of type 2 diabetes. You can read more on the Mounjaro treatment page.
How much weight do people lose on Mounjaro?
In the SURMOUNT-1 trial, participants on the 15mg dose lost on average 22.5% of body weight over 72 weeks, alongside lifestyle support. Individual results vary; not everyone reaches this.
This figure comes from a clinical trial in adults being treated for weight management, combined with diet and activity changes. The 15mg dose is the maximum licensed strength, reached gradually through titration rather than started straight away. Citation: Jastreboff AM, et al. N Engl J Med. 2022;387(3):205–216.
Is Mounjaro a treatment for type 2 diabetes?
Tirzepatide acts on the GLP-1 and GIP gut-hormone pathways that are involved in blood-sugar control, which is why type 2 diabetes is one of the weight-related conditions relevant to this class of medicine. Whether Mounjaro is appropriate for you — and how it fits alongside any existing diabetes care — is a clinical decision made by a GPhC-registered prescriber.
If you already take medicines for type 2 diabetes, it is essential to tell your prescriber. Some diabetes medicines can lower blood sugar further when combined with a GLP-1 medicine, and severe hypoglycaemia (very low blood sugar) is a rare but serious risk. Your existing diabetes treatment should never be stopped or changed without medical advice. Start a free check at our online consultation.
Who is eligible for Mounjaro in the UK?
Mounjaro is prescribed for weight management in adults aged 18 or over who have a BMI of 30 or more, or a BMI of 27 to 30 with a weight-related condition such as type 2 diabetes, high blood pressure or sleep apnoea. A prescriber confirms eligibility during the consultation.
Mounjaro is not suitable for everyone. It should not be used if you:
- are pregnant, planning pregnancy, or breastfeeding;
- have type 1 diabetes;
- have a personal or family history of medullary thyroid carcinoma or MEN2;
- have a history of pancreatitis;
- have severe gastrointestinal disease or an active eating disorder;
- have severe liver or kidney impairment;
- have a known allergy to tirzepatide.
A treatment is prescribed only if clinically appropriate after a free online consultation — a prescription is never guaranteed.
How is Mounjaro dosed?
Mounjaro is a once-weekly self-injection that starts low and increases gradually. The starting dose is 2.5mg, then it steps up through 5mg, 7.5mg, 10mg and 12.5mg to a maximum licensed dose of 15mg.
This slow titration gives your body time to adjust and helps reduce side effects such as nausea. Each increase is reviewed by a prescriber, and not everyone needs to reach the highest dose.
What are the side effects of Mounjaro?
The most common side effects of Mounjaro (affecting more than 1 in 10 people) are nausea, diarrhoea, constipation, vomiting, decreased appetite and fatigue. These are often strongest when starting or increasing the dose and tend to ease over time.
Serious but rare risks include severe allergic reaction, acute pancreatitis, severe hypoglycaemia (especially relevant if you also take diabetes medicines), severe gastrointestinal disease, and worsening of diabetic retinopathy. If you have type 2 diabetes with eye complications, discuss this with your prescriber.
You can report any suspected side effect through the MHRA Yellow Card scheme at https://yellowcard.mhra.gov.uk/.
How does Mounjaro compare with other weight-management options?
Mounjaro is one of several prescription weight-management medicines. It differs in that it acts on two gut-hormone receptors (GLP-1 and GIP), while the others listed below act on GLP-1 alone. The figures below are from separate trials and are not head-to-head comparisons.
| Medicine | How it is taken | Mechanism | Trial weight-loss figure |
|---|---|---|---|
| Mounjaro (tirzepatide) | Weekly injection | GLP-1 + GIP | 22.5% at 15mg over 72 weeks (SURMOUNT-1) |
| Wegovy injection (semaglutide) | Weekly injection | GLP-1 | 20.7% at 7.2mg over 72 weeks (STEP UP) |
| Wegovy Tablet (oral semaglutide) | Once-daily tablet on an empty stomach | GLP-1 | 16.6% at 25mg over 64 weeks (OASIS 4) |
| Foundayo (orforglipron) | Once-daily tablet, any time | Small-molecule GLP-1 | 12.4% at 36mg over 72 weeks (ATTAIN-1) |
Individual results vary; not everyone reaches these figures. Which medicine suits you depends on your health, your preferences and a prescriber's assessment — see all our treatments or the combined weight-loss injections page.
What does Mounjaro cost in the UK?
At The Weight Clinic, the online consultation is free and you only pay if a treatment is prescribed and you choose to proceed. The monthly price of Mounjaro depends on your dose:
- 2.5mg — £160/month
- 5mg — £185/month
- 7.5mg — £240/month
- 10mg — £260/month
- 12.5mg — £275/month
- 15mg — £295/month
The price covers the medicine, dispensing from our GPhC-registered pharmacy and tracked delivery. Dose should be chosen on clinical grounds with your prescriber, not on price.
How do you start?
Treatment begins with a free online consultation. A GPhC-registered independent prescriber reviews your answers to check that treatment is clinically appropriate and safe, a short video consultation is arranged where clinically needed, and — if suitable — the medicine is dispensed by our UK pharmacy and sent by tracked delivery, with ongoing prescriber support.
You can begin your free eligibility check at our start-consultation page, or learn more about The Weight Clinic.
This article is for information only and is not a substitute for personalised medical advice. Weight-loss medicines are prescription-only, are not suitable for everyone, and are prescribed only after a clinical consultation with a GPhC-registered prescriber. Individual results vary. Always speak to a UK-registered pharmacist or doctor before starting or changing any prescription medication.
